We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Rare Cell Isolation Technique Improved

By LabMedica International staff writers
Posted on 06 Nov 2012
An innovative concept has been reported for the separation of rare cells, such as prostate cancer cells or circulating tumor cells, using microfluidics. More...


The technique allows an entire blood draw to be processed, in continuous manner, in a shorter period of time, and does not rely on antibodies, which is important because not all cancer cells express antigens.

Scientists at the University of Cincinnati ( OH, USA), used inertial microfluidics to continuously and selectively collect rare cells, such as circulating tumor cells, based on their size versus other biomarkers. The advantage of inertial microfluidics in cell separation is that it can be done easily and without cumbersome equipment. This type of work is leading to an entirely new generation of testing capabilities that particularly lend themselves to direct use in the field and in physicians' offices in just about any country and any economic setting. Another area in which this device could be useful is in working with cell cultures.

The device is essentially a clear, plastic, flexible square that is relatively small, at about 12.7 mm across. The device contains four outlet ports that separate the blood into different streams, allowing the collection of outputs containing dilute plasma, red blood cells, and white blood cells. This quick, low-cost way of running a diagnostic test could potentially be used in a resource-limited setting. Ian Papautsky, PhD, an associate professor at the College of Engineering and Applied Science (Cincinnati, OH, USA), said, "If you have a mixture of multiple cells where some cells are small and other cells are big, we could separate these cell populations very easily. Anytime you need to separate based on size, we can do it using inertial microfluidics."

Prof. Papautsky explained, “There are a lot of clinical diagnostic tests that are based on blood. One of the most common tests that are done in a hospital is the complete blood count (CBC). Through this test, a wide range of conditions like anemia, malaria or leukemia are diagnosed. In all of these diagnostic tests, blood must be separated into its components, and that's what this device does. So, instead of using a big centrifuge to do it, we can do it with this little device." The microfluidic device allows for a diagnosis in less time in a much easier fashion. The study was reported at the Sixteenth International Conference on Miniaturized Systems for Chemistry and Life Sciences (microTAS) held October 28 to November 1, 2012, in Okinawa (Japan).

Related Links:

University of Cincinnati
College of Engineering and Applied Science
microTAS


Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
Automated Urinalysis Solution
UN-9000
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A new study identifies distinct metabolomic signatures in maternal blood associated with both the timing and type of early birth (Image credit: iStock)

Maternal Blood Biomarkers Identify Risk of Preterm and Early-Term Birth

Preterm and early-term births can lead to lasting complications because vital organs continue to mature during the final weeks of pregnancy. Babies born too soon face increased risks of breathing difficulties,... Read more

Molecular Diagnostics

view channel
Image: Spatial profiling of muscle-invasive bladder cancer reveals how distinct tumor cell states are organized within individual tumors (Image Credit: Shutterstock)

Spatial Map Guides Treatment Selection in Muscle-Invasive Bladder Cancer

Muscle-invasive bladder cancer is clinically heterogeneous, with patients often responding very differently to therapy. Existing biomarkers do not fully explain these disparities, limiting precision treatment... Read more

Microbiology

view channel
Image: Burkholderia pseudomallei is a soil-dwelling bacterium that causes melioidosis, a severe and potentially fatal infection that remains difficult to diagnose (Image Credit: Gavin Koh/Wikimedia Commons, CC BY-SA 4.0)

Stronger Laboratory Services Support Timely Melioidosis Diagnosis Amid Global Spread

Melioidosis, a potentially fatal infection caused by Burkholderia pseudomallei, remains difficult to recognize because its symptoms can mimic tuberculosis and other illnesses. The disease is considered... Read more

Industry

view channel
Image

QIAGEN Enhances QIAcuity Platform with Gene Expression and Multiplexing Tools

QIAGEN (Venlo, Netherlands) has introduced additions to its QIAcuity dPCR ecosystem that focus on gene expression, expanded assay content, and workflow standardization for life sciences and biopharma users.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.